Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulphate for Birth Asphyxia
NCT05707962Completed
- Sponsor
- University of Health Sciences Lahore
- Start
- Mar 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in birth asphyxia comparing Magnesium Sulfate Group with Placebo Group (2 arms). Primary endpoint: Number of participants died at 6 hours. Started Mar 2023; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
birth asphyxia
Beyond the preview
Go deeper on NCT05707962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05707962.